Evidence map›Paper›PMID 42851744›Full record

ArticleFrontiers in public health2026

Context-specific strategies for enhancing HPV vaccination: key informant perspectives from selected U.S. jurisdictions in the post-COVID-19 era.

Erika Escabí-Wojna, Natalie Álamo-Rodríguez, Mariola Acosta-Rullán, Grace Vélez-Crespo, Vivian Colón-López

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erika Escabí-WojnaDepartment of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Natalie Álamo-RodríguezDepartment of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Mariola Acosta-RullánDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Grace Vélez-CrespoCenter for Tropical Diversity, Puerto Rico Science, Technology & Research Trust, San Juan, Puerto Rico.
Vivian Colón-LópezDepartment of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.

Funding

Implementation of School-Entry Policies for Human Papillomavirus VaccinationR01CA232743 · NCI · COMPREHENSIVE CANCER CENTER/ UNIV/PR · PI COLON, VIVIAN · 2019 to 2023
$1.9M
NCI NIH HHS R01 CA232743
6 · The paper itself

Abstract

Introduction: Despite the availability of a safe and effective Human Papillomavirus (HPV) vaccine, uptake remains inconsistent across the United States (U.S.), with marked differences in vaccination coverage across states. This descriptive exploratory study examined key informant perspectives on HPV vaccination promotion across policy-engaged jurisdictions in the U.S. in the post-COVID-19 era. Methods: Semi-structured interviews were conducted with nine key informants across six U.S. jurisdictions. Classification of the interviews was based on those with existing HPV vaccine school-entry requirements or those jurisdictions with recent school-entry policy considerations. Using inductive thematic analysis, we synthesized key informant perspectives and organized themes using analytical dimensions informed by the socio-ecological model. Results: Findings highlight the importance of provider education, school-entry requirements, cancer prevention messaging, trusted messengers, culturally tailored outreach, and cross-sector partnerships as important components of HPV vaccine promotion. Barriers such as vaccine misinformation and increased hesitancy following the COVID-19 pandemic were also discussed. Discussion: These insights can inform targeted, context-specific strategies to improve HPV vaccination rates and reduce cancer disparities.

Indexed as

COVID-19Health PromotionPapillomavirus InfectionsPapillomavirus VaccinesVaccinationFemaleHuman Papillomavirus VirusesHumansInterviews as TopicSARS-CoV-2United StatesPapillomavirus Vaccinescancer preventionHPV school entry policyHPV vaccinationHPV vaccination strategiesqualitative research

Identifiers

PMID42851744
PMCPMC13646127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.